- $41.65bn
- $47.34bn
- $3.13bn
- 99
- 28
- 82
- 80
Annual income statement for MSCI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,044 | 2,249 | 2,529 | 2,856 | 3,134 |
| Cost of Revenue | |||||
| Gross Profit | 1,685 | 1,844 | 2,082 | 2,342 | 2,584 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,008 | 1,041 | 1,144 | 1,328 | 1,421 |
| Operating Profit | 1,035 | 1,208 | 1,385 | 1,529 | 1,714 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 858 | 1,044 | 1,369 | 1,356 | 1,494 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 726 | 871 | 1,149 | 1,109 | 1,202 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 726 | 871 | 1,149 | 1,109 | 1,202 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 726 | 871 | 1,149 | 1,109 | 1,202 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 9.14 | 10.8 | 14.4 | 14.1 | 15.3 |
| Dividends per Share |